#BEGIN_DRUGCARD DB03389

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
28518

# Chemical_Formula:
C5H10O5

# Chemical_IUPAC_Name:
(2S,3R,4S,5R)-oxane-2,3,4,5-tetrol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
alpha-D-Xylopyranose

# HET_ID:
XYS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5+/m1/s1

# InChI_Key:
InChIKey=SRBFZHDQGSBBOR-LECHCGJUSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C02205

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3389

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
150.1299

# Molecular_Weight_Mono:
150.05282343

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1F8Q

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.6

# Predicted_LogS:
0.91

# Predicted_Water_Solubility:
1.22e+03 g/l

# Primary_Accession_No:
DB03389

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03270

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:12 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Secreted protein

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
M64551

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
xlnA

# Drug_Target_10_Gene_Sequence:
>1434 bp
ATGGGCTCCTACGCCCTTCCCAGATCAGGTGTCCGCAGGAGCATTCGCGTCCTGCTGCTG
GCGCTGGTCGTCGGCGTACTCGGCACGGCCACCGCACTGATCGCGCCGCCGGGGGCACAC
GCCGCCGAGAGCACGCTCGGCGCCGCGGCGGCGCAGAGCGGCCGCTACTTCGGCACCGCC
ATCGCCTCGGGCAGGCTGAGCGACTCGACGTACACGTCGATCGCGGGCCGTGAGTTCAAC
ATGGTGACGGCCGAGAACGAGATGAAGATCGACGCCACCGAACCGCAGCGGGGCCAGTTC
AACTTCAGCTCCGCCGACCGCGTCTACAACTGGGCGGTGCAGAACGGCAAGCAGGTGCGC
GGCCACACCCTGGCCTGGCACTCCCAGCAGCCCGGCTGGATGCAGAGCCTCAGCGGCAGC
GCGCTGCGCCAGGCGATGATCGACCACATCAACGGCGTGATGGCCCACTACAAGGGCAAG
ATCGTCCAGTGGGACGTCGTGAACGAGGCCTTCGCCGACGGCAGTTCGGGAGCGCGGCGG
GACTCCAACCTGCAACGCAGCGGCAACGACTGGATCGAGGTCGCCTTCCGCACCGCGCGC
GCCGCCGACCCGTCCGCCAAGCTCTGCTACAACGACTACAACGTCGAGAACTGGACCTGG
GCCAAGACCCAGGCCATGTACAACATGGTGCGGGACTTCAAGCAGCGCGGCGTGCCGATC
GACTGCGTCGGCTTCCAGTCGCACTTCAACAGCGGCAGCCCCTACAACAGCAACTTCCGC
ACCACACTGCAGAACTTCGCCGCCCTCGGCGTCGACGTGGCCATCACCGAGCTGGACATC
CAGGGCGCCCCGGCCTCGACCTACGCCAACGTGACCAACGACTGCCTGGCCGTCTCGCGC
TGCCTCGGCATCACCGTCTGGGGTGTGCGCGACAGCGACTCCTGGCGGTCGGAGCAGACG
CCGTTGCTGTTCAACAACGACGGCAGCAAGAAGGCCGCGTACACCGCCGTCCTCGACGCA
CTCAACGGCGGCGACTCCTCGGAGCCCCCCGCGGACGGGGGACAGATCAAGGGCGTCGGT
TCGGGCCGCTGCCTCGACGTGCCCGACGCCAGCACCTCCGACGGCACCCAGCTCCAGCTG
TGGGACTGCCACAGCGGCACCAACCAGCAGTGGGCCGCCACTGACGCGGGCGAGCTCAGG
GTCTACGGCGACAAGTGCCTGGACGCCGCAGGCACCAGCAACGGCTCCAAGGTCCAGATC
TACAGCTGCTGGGGCGGCGACAACCAGAAGTGGCGCCTCAACTCCGACGGGTCCGTCGTC
GGCGTCCAGTCCGGCCTCTGCCTCGACGCCGTCGGGAACGGCACGGCCAACGGCACCCTG
ATCCAGCTGTACACCTGCTCCAACGGCAGCAACCAACGCTGGACCCGCACCTGA

# Drug_Target_10_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_10_General_References:
1743521	Shareck F, Roy C, Yaguchi M, Morosoli R, Kluepfel D: Sequences of three genes specifying xylanases in Streptomyces lividans. Gene. 1991 Oct 30;107(1):75-82.
8063693	Derewenda U, Swenson L, Green R, Wei Y, Morosoli R, Shareck F, Kluepfel D, Derewenda ZS: Crystal structure, at 2.6-A resolution, of the Streptomyces lividans xylanase A, a member of the F family of beta-1,4-D-glycanases. J Biol Chem. 1994 Aug 19;269(33):20811-4.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
4715

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
51163

# Drug_Target_10_Name:
Endo-1,4-beta-xylanase A

# Drug_Target_10_Number_of_Residues:
477

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF00652	Ricin_B_lectin

# Drug_Target_10_Protein_Sequence:
>Endo-1,4-beta-xylanase A
MGSYALPRSGVRRSIRVLLLALVVGVLGTATALIAPPGAHAAESTLGAAAAQSGRYFGTA
IASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVR
GHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARR
DSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPI
DCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSR
CLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGGQIKGVG
SGRCLDVPDASTSDGTQLQLWDCHSGTNQQWAATDAGELRVYGDKCLDAAGTSNGSKVQI
YSCWGGDNQKWRLNSDGSVVGVQSGLCLDAVGNGTANGTLIQLYTCSNGSNQRWTRT

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
1-41

# Drug_Target_10_Specific_Function:
Contributes to hydrolyze hemicellulose, the major component of plant cell-walls. XLNA and XLNB seem to act sequentially on the substrate to yield xylobiose and xylose as carbon sources

# Drug_Target_10_SwissProt_ID:
P26514

# Drug_Target_10_SwissProt_Name:
XYNA_STRLI

# Drug_Target_10_Synonyms:
1,4- beta-D-xylan xylanohydrolase A
EC 3.2.1.8
Endo-1,4-beta-xylanase A precursor
Xylanase A

# Drug_Target_10_Theoretical_pI:
6.61

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Cytoplasmic

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
X07723

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
xlnA

# Drug_Target_11_Gene_Sequence:
>642 bp
ATGTTTAAGTTTAAAAAGAATTTCTTAGTTGGATTATCGGCAGCTTTAATGAGTATTAGC
TTGTTTTCGGCAACCGCCTCTGCAGCTAGCACAGACTACTGGCAAAATTGGACTGATGGG
GGCGGTATAGTAAACGCTGTCAATGGGTCTGGCGGGAATTACAGTGTTAATTGGTCTAAT
ACCGGAAATTTTGTTGTTGGTAAAGGTTGGACTACAGGTTCGCCATTTAGGACGATAAAC
TATAATGCCGGAGTTTGGGCGCCGAATGGCAATGGATATTTAACTTTATATGGTTGGACG
AGATCACCTCTCATAGAATATTATGTAGTGGATTCATGGGGTACTTATAGACCTACTGGA
ACGTATAAAGGTACTGTAAAAAGTGATGGGGGTACATATGACATATATACAACTACACGT
TATAACGCACCTTCCATTGATGGCGATCGCACTACTTTTACGCAGTACTGGAGTGTTCGC
CAGTCGAAGAGACCAACTGGAAGCAACGCTACAATCACTTTCACGAATCATGTGAACGCA
TGGAAGAGCCATGGAATGAATCTGGGCAGTAATTGGGCTTACCAAGTCATGGCGACAGAA
GGATATCAAAGTAGTGGAAGTTCTAACGTAACAGTGTGGTAA

# Drug_Target_11_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_11_General_References:
3405767	Yang RC, MacKenzie CR, Narang SA: Nucleotide sequence of a Bacillus circulans xylanase gene. Nucleic Acids Res. 1988 Jul 25;16(14B):7187.
8019418	Wakarchuk WW, Campbell RL, Sung WL, Davoodi J, Yaguchi M: Mutational and crystallographic analyses of the active site residues of the Bacillus circulans xylanase. Protein Sci. 1994 Mar;3(3):467-75.
8756457	McIntosh LP, Hand G, Johnson PE, Joshi MD, Korner M, Plesniak LA, Ziser L, Wakarchuk WW, Withers SG: The pKa of the general acid/base carboxyl group of a glycosidase cycles during catalysis: a 13C-NMR study of bacillus circulans xylanase. Biochemistry. 1996 Aug 6;35(31):9958-66.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
5248

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
23359

# Drug_Target_11_Name:
Endo-1,4-beta-xylanase

# Drug_Target_11_Number_of_Residues:
213

# Drug_Target_11_PDB_ID:
1BVV

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00457	Glyco_hydro_11

# Drug_Target_11_Protein_Sequence:
>Endo-1,4-beta-xylanase
MFKFKKNFLVGLSAALMSISLFSATASAASTDYWQNWTDGGGIVNAVNGSGGNYSVNWSN
TGNFVVGKGWTTGSPFRTINYNAGVWAPNGNGYLTLYGWTRSPLIEYYVVDSWGTYRPTG
TYKGTVKSDGGTYDIYTTTRYNAPSIDGDRTTFTQYWSVRQSKRPTGSNATITFTNHVNA
WKSHGMNLGSNWAYQVMATEGYQSSGSSNVTVW

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
1-28

# Drug_Target_11_Specific_Function:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans

# Drug_Target_11_SwissProt_ID:
P09850

# Drug_Target_11_SwissProt_Name:
XYNA_BACCI

# Drug_Target_11_Synonyms:
1,4-beta-D- xylan xylanohydrolase
EC 3.2.1.8
Endo-1,4-beta-xylanase precursor
Xylanase

# Drug_Target_11_Theoretical_pI:
9.72

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Cytoplasmic

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
Not Available

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
Not Available

# Drug_Target_12_Gene_Sequence:
Not Available

# Drug_Target_12_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_12_General_References:
10571062	Kaneko S, Kuno A, Fujimoto Z, Shimizu D, Machida S, Sato Y, Yura K, Go M, Mizuno H, Taira K, Kusakabe I, Hayashi K: An investigation of the nature and function of module 10 in a family F/10 xylanase FXYN of Streptomyces olivaceoviridis E-86 by module shuffling with the Cex of Cellulomonas fimi and by site-directed mutagenesis. FEBS Lett. 1999 Oct 22;460(1):61-6.
11829503	Fujimoto Z, Kuno A, Kaneko S, Kobayashi H, Kusakabe I, Mizuno H: Crystal structures of the sugar complexes of Streptomyces olivaceoviridis E-86 xylanase: sugar binding structure of the family 13 carbohydrate binding module. J Mol Biol. 2002 Feb 8;316(1):65-78.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
5249

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
46750

# Drug_Target_12_Name:
Hydrolase

# Drug_Target_12_Number_of_Residues:
436

# Drug_Target_12_PDB_ID:
1V6X

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF00652	Ricin_B_lectin

# Drug_Target_12_Protein_Sequence:
>Hydrolase
AESTLGAAAAQSGRYFGTAIASGKLGDSAYTTIASREFNMVTAENEMKIDATEPQRGQFN
FSAGDRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSTLRQAMIDHINGVMGHYKGKI
AQWDVVNEAFSDDGSGGRRDSNLQRTGNDWIEVAFRTARAADPAAKLCYNDYNIENWTWA
KTQGVYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQ
GASSSTYAAVTNDCLAVSRCLGITVWGVRDTDSWRSGDTPLLFNGDGSKKAAYTAVLNAL
NGGSSTPPPSGGGQIKGVGSGRCLDVPNASTTDGTQVQLYDCHSATNQQWTYTDAGELRV
YGDKCLDAAGTGNGTKVQIYSCWGGDNQKWRLNSDGSIVGVQSGLCLDAVGGGTANGTLI
QLYSCSNGSNQRWTRT

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Not Available

# Drug_Target_12_SwissProt_ID:
Q7SI98

# Drug_Target_12_SwissProt_Name:
Q7SI98_STROI

# Drug_Target_12_Synonyms:
Not Available

# Drug_Target_12_Theoretical_pI:
6.50

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Cytoplasmic

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
AJ427921

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
xyl

# Drug_Target_13_Gene_Sequence:
>1281 bp
ATGAAAGTATTTTTTAAAATAACAACTTTATTGTTAATACTAATAAGCTATCAATCACTT
GCTGCATTTAATAATAACCCATCGAGTGTAGGCGCCTACAGTTCAGGGACATACCGTAAC
CTCGCACAAGAAATGGGTAAAACAAATATACAGCAAAAGGTGAATAGTACTTTTGACAAT
ATGTTTGGCTATAACAACACACAACAACTTTACTACCCGTACACCGAAAACGGTGTTTAT
AAAGCACACTACATAAAAGCAATTAACCCAGACGAAGGCGACGATATAAGAACAGAAGGG
CAATCGTGGGGAATGACCGCCGCTGTCATGCTTAATAAACAAGAAGAATTTGATAACCTA
TGGCGCTTTGCAAAAGCGTATCAAAAAAATCCAGACAATCACCCTGATGCTAAAAAACAA
GGCGTTTACGCGTGGAAACTAAAGCTTAATCAAAACGGCTTTGTTTATAAAGTGGATGAG
GGCCCCGCTCCCGATGGCGAAGAGTACTTTGCGTTTGCACTACTTAATGCCTCTGCTCGT
TGGGGGAATTCGGGTGAGTTTAACTACTACAACGATGCCATTACCATGTTAAACACAATT
AAAAATAAGCTGATGGAAAACCAAATAATCCGCTTTTCACCTTACATTGATAACCTAACA
GACCCTTCTTACCATATACCTGCGTTTTACGACTACTTTGCAAATAACGTAACTAACCAA
GCAGACAAAAATTACTGGCGACAAGTAGCCACAAAAAGTAGAACCTTACTTAAAAACCAT
TTTACAAAAGTAAGTGGTAGCCCGCATTGGAACTTACCTACATTTTTATCGCGCTTAGAT
GGCAGCCCTGTTATTGGCTACATTTTTAACGGCCAAGCAAACCCAGGTCAATGGTATGAA
TTTGATGCATGGCGCGTAATTATGAATGTGGGTTTAGACGCGCATTTAATGGGTGCTCAA
GCGTGGCATAAAAGTGCAGTTAATAAAGCACTGGGCTTTTTAAGTTATGCAAAAACAAAC
AACAGTAAAAACTGTTACGAGCAAGTGTATTCGTACGGTGGAGCGCAAAACAGAGGCTGT
GCAGGCGAAGGTCAAAAAGCCGCGAATGCAGTAGCGTTACTTGCTTCAACAAATGCTGGG
CAAGCAAATGAGTTTTTTAACGAATTTTGGTCTTTATCGCAACCAACGGGTGACTACCGT
TACTATAATGGTTCGTTATATATGTTAGCTATGCTGCATGTATCGGGCAATTTTAAGTTT
TATAACAACACGTTTAATTAA

# Drug_Target_13_General_Function:
Involved in catalytic activity

# Drug_Target_13_General_References:
12089151	Collins T, Meuwis MA, Stals I, Claeyssens M, Feller G, Gerday C: A novel family 8 xylanase, functional and physicochemical characterization. J Biol Chem. 2002 Sep 20;277(38):35133-9. Epub 2002 Jun 27.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
5250

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
48407

# Drug_Target_13_Name:
Endo-1,4-beta-xylanase

# Drug_Target_13_Number_of_Residues:
426

# Drug_Target_13_PDB_ID:
1H13

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF01270	Glyco_hydro_8

# Drug_Target_13_Protein_Sequence:
>Endo-1,4-beta-xylanase
MKVFFKITTLLLILISYQSLAAFNNNPSSVGAYSSGTYRNLAQEMGKTNIQQKVNSTFDN
MFGYNNTQQLYYPYTENGVYKAHYIKAINPDEGDDIRTEGQSWGMTAAVMLNKQEEFDNL
WRFAKAYQKNPDNHPDAKKQGVYAWKLKLNQNGFVYKVDEGPAPDGEEYFAFALLNASAR
WGNSGEFNYYNDAITMLNTIKNKLMENQIIRFSPYIDNLTDPSYHIPAFYDYFANNVTNQ
ADKNYWRQVATKSRTLLKNHFTKVSGSPHWNLPTFLSRLDGSPVIGYIFNGQANPGQWYE
FDAWRVIMNVGLDAHLMGAQAWHKSAVNKALGFLSYAKTNNSKNCYEQVYSYGGAQNRGC
AGEGQKAANAVALLASTNAGQANEFFNEFWSLSQPTGDYRYYNGSLYMLAMLHVSGNFKF
YNNTFN

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
1-21

# Drug_Target_13_Specific_Function:
Not Available

# Drug_Target_13_SwissProt_ID:
Q8RJN8

# Drug_Target_13_SwissProt_Name:
Q8RJN8_PSEHA

# Drug_Target_13_Synonyms:
EC 3.2.1.8
Endo-1,4-beta-xylanase precursor

# Drug_Target_13_Theoretical_pI:
8.67

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Apical cell membrane

# Drug_Target_14_Chromosome_Location:
2

# Drug_Target_14_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
X07994

# Drug_Target_14_GenBank_ID_Protein:
34400

# Drug_Target_14_GeneCard_ID:
LCT

# Drug_Target_14_Gene_Name:
LCT

# Drug_Target_14_Gene_Sequence:
>5784 bp
ATGGAGCTGTCTTGGCATGTAGTCTTTATTGCCCTGCTAAGTTTTTCATGCTGGGGGTCA
GACTGGGAGTCTGATAGAAATTTCATTTCCACCGCTGGTCCTCTAACCAATGACTTGCTG
CACAACCTGAGTGGTCTCCTGGGAGACCAGAGTTCTAACTTTGTAGCAGGGGACAAAGAC
ATGTATGTTTGTCACCAGCCACTGCCCACTTTCCTGCCAGAATACTTCAGCAGTCTCCAT
GCCAGTCAGATCACCCATTATAAGGTATTTCTGTCATGGGCACAGCTCCTCCCAGCAGGA
AGCACCCAGAATCCAGACGAGAAAACAGTGCAGTGCTACCGGCGACTCCTCAAGGCCCTC
AAGACTGCACGGCTTCAGCCCATGGTCATCCTGCACCACCAGACCCTCCCTGCCAGCACC
CTCCGGAGAACCGAAGCCTTTGCTGACCTCTTCGCCGACTATGCCACATTCGCCTTCCAC
TCCTTCGGGGACCTAGTTGGGATCTGGTTCACCTTCAGTGACTTGGAGGAAGTGATCAAG
GAGCTTCCCCACCAGGAATCAAGAGCGTCACAACTCCAGACCCTCAGTGATGCCCACAGA
AAAGCCTATGAGATTTACCACGAAAGCTATGCTTTTCAGGGCGGAAAACTCTCTGTTGTC
CTGCGAGCTGAAGATATCCCGGAGCTCCTGCTAGAACCACCCATATCTGCGCTTGCCCAG
GACACGGTCGATTTCCTCTCTCTTGATTTGTCTTATGAATGCCAAAATGAGGCAAGTCTG
CGGCAGAAGCTGAGTAAATTGCAGACCATTGAGCCAAAAGTGAAAGTTTTCATCTTCAAC
CTAAAACTCCCAGACTGCCCCTCCACCATGAAGAACCCAGCCAGTCTGCTCTTCAGCCTT
TTTGAAGCCATAAATAAAGACCAAGTGCTCACCATTGGGTTTGATATTAATGAGTTTCTG
AGTTGTTCATCAAGTTCCAAGAAAAGCATGTCTTGTTCTCTGACTGGCAGCCTGGCCCTT
CAGCCTGACCAGCAGCAGGACCACGAGACCACGGACTCCTCTCCTGCCTCTGCCTATCAG
AGAGTCTGGGAAGCATTTGCCAATCAGTCCAGAGCGGAAAGGGATGCCTTCCTGCAGGAT
ACTTTCCCTGAAGGCTTCCTCTGGGGTGCCTCCACAGGAGCCTTTAACGTGGAAGGAGGC
TGGGCCGAGGGTGGGAGAGGGGTGAGCATCTGGGATCCACGCAGGCCCCTGAACACCACT
GAGGGCCAAGCGACGCTGGAGGTGGCCAGCGACAGTTACCACAAGGTAGCCTCTGACGTC
GCCCTGCTTTGCGGCCTCCGGGCTCAGGTGTACAAGTTCTCCATCTCCTGGTCCCGGATC
TTCCCCATGGGGCACGGGAGCAGCCCCAGCCTCCCAGGCGTTGCCTACTACAACAAGCTG
ATTGACAGGCTACAGGATGCGGGCATCGAGCCCATGGCCACGCTGTTCCACTGGGACCTG
CCTCAGGCCCTGCAGGATCATGGTGGATGGCAGAATGAGAGCGTGGTGGATGCCTTCCTG
GACTATGCGGCCTTCTGCTTCTCCACATTTGGGGACCGTGTGAAGCTGTGGGTGACCTTC
CATGAGCCGTGGGTGATGAGCTACGCAGGCTATGGCACCGGCCAGCACCCTCCCGGCATC
TCTGACCCAGGAGTGGCCTCTTTTAAGGTGGCTCACTTGGTCCTCAAGGCTCATGCCAGA
ACTTGGCACCACTACAACAGCCATCATCGCCCACAGCAGCAGGGGCACGTGGGCATTGTG
CTGAACTCAGACTGGGCAGAACCCCTGTCTCCAGAGAGGCCTGAGGACCTGAGAGCCTCT
GAGCGCTTCTTGCACTTCATGCTGGGCTGGTTTGCACACCCCGTCTTTGTGGATGGAGAC
TACCCAGCCACCCTGAGGACCCAGATCCAACAGATGAACAGACAGTGCTCCCATCCTGTG
GCTCAACTCCCCGAGTTCACAGAGGCAGAGAAGCAGCTCCTGAAAGGCTCTGCTGATTTT
CTGGGTCTGTCGCATTACACCTCCCGCCTCATCAGCAACGCCCCACAAAACACCTGCATC
CCTAGCTATGATACCATTGGAGGCTTCTCCCAACACGTGAACCATGTGTGGCCCCAGACC
TCATCCTCTTGGATTCGTGTGGTGCCCTGGGGGATAAGGAGGCTGTTGCAGTTTGTATCC
CTGGAATACACAAGAGGAAAAGTTCCAATATACCTTGCCGGGAATGGCATGCCCATAGGG
GAAAGTGAAAATCTCTTTGATGATTCCTTAAGAGTAGACTACTTCAATCAATATATCAAT
GAGGTGCTCAAGGCTATCAAGGAAGACTCTGTGGATGTTCGTTCCTACATTGCTCGTTCC
CTCATTGATGGCTTCGAAGGCCCTTCTGGTTACAGCCAGCGGTTTGGCCTGCACCACGTC
AACTTCAGCGACAGCAGCAAGTCAAGGACTCCCAGGAAATCTGCCTACTTTTTCACTAGC
ATCATAGAAAAGAACGGTTTCCTCACCAAGGGGGCAAAAAGACTGCTACCACCTAATACA
GTAAACCTCCCCTCCAAAGTCAGAGCCTTCACTTTTCCATCTGAGGTGCCCTCCAAGGCT
AAAGTCGTTTGGGAAAAGTTCTCCAGCCAACCCAAGTTCGAAAGAGATTTGTTCTACCAC
GGGACGTTTCGGGATGACTTTCTGTGGGGCGTGTCCTCTTCCGCTTATCAGATTGAAGGC
GCGTGGGATGCCGATGGCAAAGGCCCCAGCATCTGGGATAACTTTACCCACACACCAGGG
AGCAATGTGAAAGACAATGCCACTGGAGACATCGCCTGTGACAGCTATCACCAGCTGGAT
GCCGATCTGAATATGCTCCGAGCTTTGAAGGTGAAGGCCTACCGCTTCTCTATCTCCTGG
TCTCGGATTTTCCCAACTGGGAGAAACAGCTCTATCAACAGTCATGGGGTTGATTATTAC
AACAGGCTGATCAATGGCTTGGTGGCAAGCAACATCTTTCCCATGGTGACATTGTTCCAT
TGGGACCTGCCCCAGGCCCTCCAGGATATCGGAGGCTGGGAGAATCCTGCCTTGATTGAC
TTGTTTGACAGCTACGCAGACTTTTGTTTCCAGACCTTTGGTGATAGAGTCAAGTTTTGG
ATGACTTTTAATGAGCCCATGTACCTGGCATGGCTAGGTTATGGCTCAGGGGAATTTCCC
CCAGGGGTGAAGGACCCAGGCTGGGCACCATATAGGATAGCCCACACCGTCATCAAAGCC
CATGCCAGAGTCTATCACACGTACGATGAGAAATACAGGCAGGAGCAGAAGGGGGTCATC
TCGCTGAGCCTCAGTACACACTGGGCAGAGCCCAAGTCACCAGGGGTCCCCAGAGATGTG
GAAGCCGCTGACCGAATGCTGCAGTTCTCCCTGGGCTGGTTTGCTCACCCCATTTTTAGA
AACGGAGACTATCCTGACACCATGAAGTGGAAAGTGGGGAACAGGAGTGAACTGCAGCAC
TTAGCCACCTCCCGCCTGCCAAGCTTCACTGAGGAAGAGAAGAGGTTCATCAGGGCGACG
GCCGACGTCTTCTGCCTCAACACGTACTACTCCAGAATCGTGCAGCACAAAACACCCAGG
CTAAACCCACCCTCCTACGAAGACGACCAGGAGATGGCTGAGGAGGAGGACCCTTCGTGG
CCTTCCACGGCAATGAACAGAGCTGCGCCCTGGGGGACGCGAAGGCTGCTGAACTGGATC
AAGGAAGAGTATGGTGACATCCCCATTTACATCACCGAAAACGGAGTGGGGCTGACCAAT
CCGAACACGGAGGATACTGATAGGATATTTTACCACAAAACCTACATCAATGAGGCTTTG
AAAGCCTACAGGCTCGATGGTATAGACCTTCGAGGGTATGTCGCCTGGTCTCTGATGGAC
AACTTTGAGTGGCTAAATGGCTACACGGTCAAGTTTGGACTGTACCATGTTGATTTCAAC
AACACGAACAGGCCTCGCACAGCAAGAGCCTCCGCCAGGTACTACACAGAGGTCATTACC
AACAACGGCATGCCACTGGCCAGGGAGGATGAGTTTCTGTACGGACGGTTTCCTGAGGGC
TTCATCTGGAGTGCAGCTTCTGCTGCATATCAGATTGAAGGTGCGTGGAGAGCAGATGGC
AAAGGACTCAGCATTTGGGACACGTTTTCTCACACACCACTGAGGGTTGAGAACGATGCC
ATTGGAGACGTGGCCTGTGACAGTTATCACAAGATTGCTGAGGATCTGGTCACCCTGCAG
AACCTGGGTGTGTCCCACTACCGTTTTTCCATCTCCTGGTCTCGCATCCTCCCTGATGGA
ACCACCAGGTACATCAATGAAGCGGGCCTGAACTACTACGTGAGGCTCATCGATACACTG
CTGGCCGCCAGCATCCAGCCCCAGGTGACCATTTACCACTGGGACCTACCACAGACGCTC
CAAGATGTAGGAGGCTGGGAGAATGAGACCATCGTGCAGCGGTTTAAGGAGTATGCAGAT
GTGCTCTTCCAGAGGCTGGGAGACAAGGTGAAGTTTTGGATCACGTTGAATGAGCCCTTT
GTCATTGCTTACCAGGGCTATGGCTACGGAACAGCAGCTCCAGGAGTCTCCAATAGGCCT
GGCACTGCCCCCTACATTGTTGGCCACAATCTAATAAAGGCTCATGCTGAGGCCTGGCAT
CTGTACAACGATGTGTACCGCGCCAGTCAAGGTGGCGTGATTTCCATCACCATCAGCAGT
GACTGGGCTGAACCCAGAGATCCCTCTAACCAGGAGGATGTGGAGGCAGCCAGGAGATAT
GTTCAGTTCATGGGAGGCTGGTTTGCACATCCTATTTTCAAGAATGGAGATTACAATGAG
GTGATGAAGACGCGGATCCGTGACAGGAGCTTGGCTGCAGGCCTCAACAAGTCTCGGCTG
CCAGAATTTACAGAGAGTGAGAAGAGGAGGATCAACGGCACCTATGACTTTTTTGGGTTC
AATCACTACACCACTGTCCTCGCCTACAACCTCAACTATGCCACTGCCATCTCTTCTTTT
GATGCAGACAGAGGAGTTGCTTCCATCGCAGATCGCTCGTGGCCAGACTCTGGCTCCTTC
TGGCTGAAGATGACGCCTTTTGGCTTCAGGAGGATCCTGAACTGGTTAAAGGAGGAATAC
AATGACCCTCCAATTTATGTCACAGAGAATGGAGTGTCCCAGCGGGAAGAAACAGACCTC
AATGACACTGCAAGGATCTACTACCTTCGGACTTACATCAATGAGGCCCTCAAAGCTGTG
CAGGACAAGGTGGACCTTCGAGGATACACAGTTTGGAGTGCGATGGACAATTTTGAGTGG
GCCACAGGCTTTTCAGAGAGATTTGGTCTGCATTTTGTGAACTACAGTGACCCTTCTCTG
CCAAGGATCCCCAAAGCATCAGCGAAGTTCTACGCCTCTGTGGTCCGATGCAATGGCTTC
CCTGACCCCGCTACAGGGCCTCACGCTTGTCTCCACCAGCCAGATGCTGGACCCACCATC
AGCCCCGTGAGACAGGAGGAGGTGCAGTTCCTGGGGCTAATGCTCGGCACCACAGAAGCA
CAGACAGCTTTGTACGTTCTCTTTTCTCTTGTGCTTCTTGGAGTCTGTGGCTTGGCATTT
CTGTCATACAAGTACTGCAAGCGCTCTAAGCAAGGGAAAACACAACGAAGCCAACAGGAA
TTGAGCCCGGTGTCTTCATTCTGA

# Drug_Target_14_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_14_General_References:
11788828	Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I: Identification of a variant associated with adult-type hypolactasia. Nat Genet. 2002 Feb;30(2):233-7. Epub 2002 Jan 14.
15815621	Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.
16400612	Kuokkanen M, Kokkonen J, Enattah NS, Ylisaukko-Oja T, Komu H, Varilo T, Peltonen L, Savilahti E, Jarvela I: Mutations in the translated region of the lactase gene (LCT) underlie congenital lactase deficiency. Am J Hum Genet. 2006 Feb;78(2):339-44. Epub 2005 Dec 15.
17053785	Wang Y, Du D, Fang L, Yang G, Zhang C, Zeng R, Ullrich A, Lottspeich F, Chen Z: Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J. 2006 Nov 1;25(21):5058-70. Epub 2006 Oct 19.
1902057	Boll W, Wagner P, Mantei N: Structure of the chromosomal gene and cDNAs coding for lactase-phlorizin hydrolase in humans with adult-type hypolactasia or persistence of lactase. Am J Hum Genet. 1991 May;48(5):889-902.
2460343	Mantei N, Villa M, Enzler T, Wacker H, Boll W, James P, Hunziker W, Semenza G: Complete primary structure of human and rabbit lactase-phlorizin hydrolase: implications for biosynthesis, membrane anchoring and evolution of the enzyme. EMBO J. 1988 Sep;7(9):2705-13.

# Drug_Target_14_HGNC_ID:
GNC:6530

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
6847

# Drug_Target_14_Locus:
2q21

# Drug_Target_14_Molecular_Weight:
218570.8

# Drug_Target_14_Name:
Lactase-phlorizin hydrolase

# Drug_Target_14_Number_of_Residues:
1927

# Drug_Target_14_PDB_ID:
Not Available

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00232	Glyco_hydro_1

# Drug_Target_14_Protein_Sequence:
>Lactase-phlorizin hydrolase
MELSWHVVFIALLSFSCWGSDWESDRNFISTAGPLTNDLLHNLSGLLGDQSSNFVAGDKD
MYVCHQPLPTFLPEYFSSLHASQITHYKVFLSWAQLLPAGSTQNPDEKTVQCYRRLLKAL
KTARLQPMVILHHQTLPASTLRRTEAFADLFADYATFAFHSFGDLVGIWFTFSDLEEVIK
ELPHQESRASQLQTLSDAHRKAYEIYHESYAFQGGKLSVVLRAEDIPELLLEPPISALAQ
DTVDFLSLDLSYECQNEASLRQKLSKLQTIEPKVKVFIFNLKLPDCPSTMKNPASLLFSL
FEAINKDQVLTIGFDINEFLSCSSSSKKSMSCSLTGSLALQPDQQQDHETTDSSPASAYQ
RVWEAFANQSRAERDAFLQDTFPEGFLWGASTGAFNVEGGWAEGGRGVSIWDPRRPLNTT
EGQATLEVASDSYHKVASDVALLCGLRAQVYKFSISWSRIFPMGHGSSPSLPGVAYYNKL
IDRLQDAGIEPMATLFHWDLPQALQDHGGWQNESVVDAFLDYAAFCFSTFGDRVKLWVTF
HEPWVMSYAGYGTGQHPPGISDPGVASFKVAHLVLKAHARTWHHYNSHHRPQQQGHVGIV
LNSDWAEPLSPERPEDLRASERFLHFMLGWFAHPVFVDGDYPATLRTQIQQMNRQCSHPV
AQLPEFTEAEKQLLKGSADFLGLSHYTSRLISNAPQNTCIPSYDTIGGFSQHVNHVWPQT
SSSWIRVVPWGIRRLLQFVSLEYTRGKVPIYLAGNGMPIGESENLFDDSLRVDYFNQYIN
EVLKAIKEDSVDVRSYIARSLIDGFEGPSGYSQRFGLHHVNFSDSSKSRTPRKSAYFFTS
IIEKNGFLTKGAKRLLPPNTVNLPSKVRAFTFPSEVPSKAKVVWEKFSSQPKFERDLFYH
GTFRDDFLWGVSSSAYQIEGAWDADGKGPSIWDNFTHTPGSNVKDNATGDIACDSYHQLD
ADLNMLRALKVKAYRFSISWSRIFPTGRNSSINSHGVDYYNRLINGLVASNIFPMVTLFH
WDLPQALQDIGGWENPALIDLFDSYADFCFQTFGDRVKFWMTFNEPMYLAWLGYGSGEFP
PGVKDPGWAPYRIAHAVIKAHARVYHTYDEKYRQEQKGVISLSLSTHWAEPKSPGVPRDV
EAADRMLQFSLGWFAHPIFRNGDYPDTMKWKVGNRSELQHLATSRLPSFTEEEKRFIRAT
ADVFCLNTYYSRIVQHKTPRLNPPSYEDDQEMAEEEDPSWPSTAMNRAAPWGTRRLLNWI
KEEYGDIPIYITENGVGLTNPNTEDTDRIFYHKTYINEALKAYRLDGIDLRGYVAWSLMD
NFEWLNGYTVKFGLYHVDFNNTNRPRTARASARYYTEVITNNGMPLAREDEFLYGRFPEG
FIWSAASAAYQIEGAWRADGKGLSIWDTFSHTPLRVENDAIGDVACDSYHKIAEDLVTLQ
NLGVSHYRFSISWSRILPDGTTRYINEAGLNYYVRLIDTLLAASIQPQVTIYHWDLPQTL
QDVGGWENETIVQRFKEYADVLFQRLGDKVKFWITLNEPFVIAYQGYGYGTAAPGVSNRP
GTAPYIVGHNLIKAHAEAWHLYNDVYRASQGGVISITISSDWAEPRDPSNQEDVEAARRY
VQFMGGWFAHPIFKNGDYNEVMKTRIRDRSLAAGLNKSRLPEFTESEKRRINGTYDFFGF
NHYTTVLAYNLNYATAISSFDADRGVASIADRSWPDSGSFWLKMTPFGFRRILNWLKEEY
NDPPIYVTENGVSQREETDLNDTARIYYLRTYINEALKAVQDKVDLRGYTVWSAMDNFEW
ATGFSERFGLHFVNYSDPSLPRIPKASAKFYASVVRCNGFPDPATGPHACLHQPDAGPTI
SPVRQEEVQFLGLMLGTTEAQTALYVLFSLVLLGVCGLAFLSYKYCKRSKQGKTQRSQQE
LSPVSSF

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
1-19

# Drug_Target_14_Specific_Function:
LPH splits lactose in the small intestine

# Drug_Target_14_SwissProt_ID:
P09848

# Drug_Target_14_SwissProt_Name:
LPH_HUMAN

# Drug_Target_14_Synonyms:
Lactase
Lactase-glycosylceramidase
Phlorizin hydrolase

# Drug_Target_14_Theoretical_pI:
6.30

# Drug_Target_14_Transmembrane_Regions:
1883-1901

# Drug_Target_15_Cellular_Location:
Cytoplasmic

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
Not Available

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
AF049493

# Drug_Target_15_GenBank_ID_Protein:
Not Available

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
xynC

# Drug_Target_15_Gene_Sequence:
>1140 bp
ATGAATCTTTCACGTCGGCAACTTCTCGCACTAACCAGTGCGGGCATCGCGATGGGCCAA
GCCAGCAAGCTTGCGGCAGCAACCAAAGCGGCGGAGCAAACCGGGCTTAAAAGTGCCTAC
AAGGATAACTTTTTAATCGGCGCCGCACTCAATGCGACTATTGCGAGCGGTGCGGATGAA
CGCCTTAATACCTTGATTGCCAAAGAGTTTAATTCAATTACGCCAGAAAACTGCATGAAA
TGGGGTGTATTGCGCGATGCCCAAGGCCAGTGGAATTGGAAAGACGCCGATGCATTTGTT
GCATTTGGCACCAAACACAATCTGCACATGGTCGGCCACACCTTGGTATGGCACAGCCAG
ATCCACGATGAAGTATTTAAAAACGCCGATGGTAGTTACATCAGCAAAGCTGCGTTGCAG
AAAAAAATGGAAGAGCACATCACCACCCTCGCGGGCCGCTATAAAGGCAAACTTGCCGCC
TGGGATGTAGTGAATGAAGCGGTGGGCGATGATTTGAAAATGCGTGACAGCCATTGGTAC
AAGATTATGGGCGATGATTTTATCTACAACGCCTTTACCCTTGCCAATGAAGTCGACCCC
AAAGCGCACTTGATGTACAACGATTACAACATTGAACGCACCGGCAAACGCGAAGCAACA
GTGGAAATGATCGAGCGCTTGCAAAAACGCGGCATGCCGATTCACGGTTTAGGAATTCAA
GGACATTTGGGAATAGATACTCCGCCTATTGCCGAGATCGAAAAGAGTATTATCGCCTTC
GCCAAATTGGGCCTGCGCGTGCACTTCACCGAGCTGGATGTAGACGTACTGCCTTCGGTA
TGGGAACTGCCGGTAGCTGAAGTTTCTACCCGCTTTGAATACAAACCCGAGCGCGACCCC
TATACCAAAGGTTTGCCGCAGGAAATGCAAGACAAATTGGCAAAACGCTACGAAGATTTA
TTCAAATTATTTATCAAACACAGCGATAAAATCGACCGCGCCACCTTCTGGGGTGTAAGC
GATGACGCAAGCTGGCTCAACGGCTTCCCGATTCCCGGTCGCACCAACTACCCACTGTTG
TTTGATCGCAAACTACAACCGAAAGACGCTTACTTCCGTTTACTGGATTTAAAACGTTAA

# Drug_Target_15_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_15_General_References:
Not Available

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
4808

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
42914

# Drug_Target_15_Name:
Endoxylanase

# Drug_Target_15_Number_of_Residues:
379

# Drug_Target_15_PDB_ID:
1UR2

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF00331	Glyco_hydro_10

# Drug_Target_15_Protein_Sequence:
>Endoxylanase
MNLSRRQLLALTSAGIAMGQASKLAAATKAAEQTGLKSAYKDNFLIGAALNATIASGADE
RLNTLIAKEFNSITPENCMKWGVLRDAQGQWNWKDADAFVAFGTKHNLHMVGHTLVWHSQ
IHDEVFKNADGSYISKAALQKKMEEHITTLAGRYKGKLAAWDVVNEAVGDDLKMRDSHWY
KIMGDDFIYNAFTLANEVDPKAHLMYNDYNIERTGKREATVEMIERLQKRGMPIHGLGIQ
GHLGIDTPPIAEIEKSIIAFAKLGLRVHFTELDVDVLPSVWELPVAEVSTRFEYKPERDP
YTKGLPQEMQDKLAKRYEDLFKLFIKHSDKIDRATFWGVSDDASWLNGFPIPGRTNYPLL
FDRKLQPKDAYFRLLDLKR

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Not Available

# Drug_Target_15_SwissProt_ID:
O68541

# Drug_Target_15_SwissProt_Name:
O68541_9GAMM

# Drug_Target_15_Synonyms:
Not Available

# Drug_Target_15_Theoretical_pI:
7.89

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Cytoplasmic

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
AB024519

# Drug_Target_16_GenBank_ID_Protein:
4520330

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
spoII

# Drug_Target_16_Gene_Sequence:
>1641 bp
ATGAAAAATCAGTTTCAATATTGTTGTATTGTCATTTTGTCTGTAGTGATGTTATTTGTA
TCATTATTAATTCCGCAAGCGAGTTCGGCAGCTGTAAATGGAAAAGGAATGAATCCAGAT
TACAAAGCATATTTAATGGCGCCATTAAAAAAGATACCGGAAGTAACAAATTGGGAGACA
TTTGAAAATGATTTACGATGGGCAAAACAAAATGGTTTTTATGCTATTACAGTTGATTTT
TGGTGGGGGGATATGGAAAAGAACGGAGATCAGCAATTTGATTTTTCATACGCACAGCGC
TTTGCTCAATCGGTAAAAAATGCAGGTATGAAAATGATTCCTATTATTTCCACACATCAG
TGCGGTGGAAATGTTGGGGATGATTGCAATGTACCAATTCCTTCATGGGTTTGGAATCAA
AAATCCGATGATAGCCTTTATTTTAAGTCTGAAACAGGAACTGTCAATAAAGAAACATTA
AATCCACTTGCTTCAGATGTAATTCGAAAGGAATATGGTGAACTATATACAGCATTCGCA
GCAGCTATGAAACCGTATAAAGATGTAATTGCAAAAATATATTTATCTGGAGGACCAGCT
GGTGAACTAAGATATCCTTCATATACAACTTCCGATGGGACAGGATATCCCTCACGTGGA
AAGTTTCAAGCGTATACAGAGTTTGCAAAATCTAAATTTCGTTTATGGGTATTAAATAAA
TATGGTTCTCTAAATGAAGTGAATAAAGCATGGGGCACGAAACTGATTTCAGAGTTAGCA
ATTTTACCACCAAGCGATGGGGAACAATTCTTAATGAATGGATATCTTTCTATGTATGGA
AAAGACTATTTAGAATGGTATCAGGGCATCTTGGAAAATCATACAAAATTAATTGGTGAA
TTAGCACATAACGCATTTGACACAACTTTCCAAGTACCAATTGGTGCAAAAATTGCAGGC
GTACATTGGCAATATAATAACCCAACAATACCTCATGGAGCTGAAAAGCCTGCAGGGTAT
AATGATTATAGCCATTTACTTGATGCTTTCAAAAGTGCAAAGCTAGATGTAACATTTACT
TGCTTAGAAATGACAGATAAAGGTAGTTATCCGGAATATTCAATGCCAAAAACATTGGTA
CAAAATATTGCAACATTAGCCAATGAAAAGGGAATTGTATTAAACGGTGAAAATGCTTTA
AGTATCGGAAATGAAGAAGAGTATAAAAGAGTTGCAGAAATGGCTTTCAATTATAATTTT
GCTGGATTTACGTTACTTCGTTATCAAGATGTAATGTATAACAATTCATTAATGGGGAAA
TTTAAAGATTTATTAGGTGTAACCCCTGTTATGCAAACGATTGTAGTAAAAAATGTTCCT
ACAACAATAGGAGATACTGTTTATATTACTGGGAATCGTGCGGAATTAGGAAGTTGGGAC
ACAAAACAGTATCCAATTCAATTATATTATGATTCTCATAGTAATGATTGGAGAGGAAAT
GTTGTGTTGCCAGCTGAAAGAAATATAGAATTTAAAGCATTTATTAAAAGTAAAGATGGA
ACGGTTAAATCATGGCAAACAATACAACAAAGTTGGAATCCAGTGCCACTAAAGACTACC
TCTCATACAAGTAGTTGGTAA

# Drug_Target_16_General_Function:
Involved in beta-amylase activity

# Drug_Target_16_General_References:
10353816	Mikami B, Adachi M, Kage T, Sarikaya E, Nanmori T, Shinke R, Utsumi S: Structure of raw starch-digesting Bacillus cereus beta-amylase complexed with maltose. Biochemistry. 1999 Jun 1;38(22):7050-61.
8434930	Nanmori T, Nagai M, Shimizu Y, Shinke R, Mikami B: Cloning of the beta-amylase gene from Bacillus cereus and characteristics of the primary structure of the enzyme. Appl Environ Microbiol. 1993 Feb;59(2):623-7.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
3365

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
61629

# Drug_Target_16_Name:
Beta-amylase

# Drug_Target_16_Number_of_Residues:
546

# Drug_Target_16_PDB_ID:
1J12

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF00686	CBM_20
PF01373	Glyco_hydro_14

# Drug_Target_16_Protein_Sequence:
>Beta-amylase precursor
MKNQFQYCCIVILSVVMLFVSLLIPQASSAAVNGKGMNPDYKAYLMAPLKKIPEVTNWET
FENDLRWAKQNGFYAITVDFWWGDMEKNGDQQFDFSYAQRFAQSVKNAGMKMIPIISTHQ
CGGNVGDDCNVPIPSWVWNQKSDDSLYFKSETGTVNKETLNPLASDVIRKEYGELYTAFA
AAMKPYKDVIAKIYLSGGPAGELRYPSYTTSDGTGYPSRGKFQAYTEFAKSKFRLWVLNK
YGSLNEVNKAWGTKLISELAILPPSDGEQFLMNGYLSMYGKDYLEWYQGILENHTKLIGE
LAHNAFDTTFQVPIGAKIAGVHWQYNNPTIPHGAEKPAGYNDYSHLLDAFKSAKLDVTFT
CLEMTDKGSYPEYSMPKTLVQNIATLANEKGIVLNGENALSIGNEEEYKRVAEMAFNYNF
AGFTLLRYQDVMYNNSLMGKFKDLLGVTPVMQTIVVKNVPTTIGDTVYITGNRAELGSWD
TKQYPIQLYYDSHSNDWRGNVVLPAERNIEFKAFIKSKDGTVKSWQTIQQSWNPVPLKTT
SHTSSW

# Drug_Target_16_Reaction:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides so as to remove successive maltose units from the non-reducing ends of the chains ALL_REAC (other) R02112 R06159(G)

# Drug_Target_16_Signals:
1-30

# Drug_Target_16_Specific_Function:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides so as to remove successive maltose units from the non-reducing ends of the chains

# Drug_Target_16_SwissProt_ID:
P36924

# Drug_Target_16_SwissProt_Name:
AMYB_BACCE

# Drug_Target_16_Synonyms:
1,4-alpha-D-glucan maltohydrolase
Beta-amylase precursor
EC 3.2.1.2

# Drug_Target_16_Theoretical_pI:
6.72

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U27584

# Drug_Target_1_GenBank_ID_Protein:
1002527

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cslB

# Drug_Target_1_Gene_Sequence:
>1521 bp
ATGAAGATGCTGAATAAACTAGCCGGATACTTATTGCCGATCATGGTGCTGCTGAATGTG
GCACCATGCTTAGGTCAGGTTGTTGCTTCAAATGAAACTTTATACCAGGTTGTAAAGGAG
GTAAAACCCGGTGGTCTGGTACAGATTGCCGATGGGACTTATAAAGATGTTCAGCTGATT
GTCAGCAATTCAGGAAAATCTGGTTTGCCCATCACTATTAAAGCCCTGAACCCGGGTAAG
GTTTTTTTTACCGGAGATGCTAAAGTAGAGCTGAGGGGCGAGCACCTGATACTGGAAGGC
ATCTGGTTTAAAGACGGGAACAGAGCTATTCAGGCATGGAAATCACATGGACCCGGATTG
GTGGCTATATATGGTAGCTATAACCGCATTACCGCATGTGTATTTGATTGTTTTGATGAA
GCCAATTCTGCTTACATTACTACTTCGCTTACCGAAGACGGAAAGGTACCTCAACATTGC
CGCATAGACCATTGCAGTTTTACCGATAAGATCACTTTTGACCAGGTAATTAACCTGAAC
AATACAGCCAGAGCTATTAAAGACGGTTCGGTGGGAGGACCGGGGATGTACCATCGTGTT
GATCACTGTTTTTTTTCCAATCCGCAAAAACCGGGTAATGCCGGAGGGGGAATCAGGATT
GGCTATTACCGTAATGATATAGGCCGTTGTCTGGTAGACTCTAACCTGTTTATGCGTCAG
GATTCGGAAGCAGAGATCATCACCAGCAAATCGCAGGAAAATGTTTATTATGGTAATACT
TACCTGAATTGCCAGGGCACCATGAACTTTCGTCACGGTGATCATCAGGTGGCCATTAAC
AATTTTTATATAGGCAATGACCAGCGATTTGGATACGGGGGAATGTTTGTTTGGGGAAGC
AGGCATGTCATAGCCTGTAATTATTTTGAGCTGTCCGAAACCATAAAGTCGAGGGGGAAC
GCCGCATTGTATTTAAACCCCGGTGCTATGGCTTCGGAGCATGCTCTTGCTTTCGATATG
TTGATAGCCAACAACGCTTTCATCAATGTAAATGGGTATGCCATCCATTTTAATCCATTG
GATGAGCGCAGAAAAGAATATTGTGCAGCCAATAGGCTTAAGTTCGAAACCCCGCACCAG
CTAATGTTAAAAGGCAATCTTTTCTTTAAGGATAAACCTTATGTTTACCCATTTTTTAAA
GATGATTATTTTATAGCAGGGAAAAATAGCTGGACTGGTAATGTAGCCTTAGGTGTGGAA
AAGGGAATCCCTGTTAACATTTCGGCCAATAGGTCTGCCTATAAGCCGGTAAAAATTAAA
GATATCCAGCCCATAGAAGGAATCGCTCTTGATCTCAATGCGCTGATCAGCAAAGGCATT
ACAGGAAAGCCCCTTAGCTGGGATGAAGTAAGGCCCTACTGGTTAAAAGAAATGCCCGGG
ACGTATGCTTTAACGGCCAGGCTTTCTGCAGATAGGGCTGCAAAGTTTAAAGCCGTAATT
AAAAGAAATAAAGAGCACTGA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
10600383	Huang W, Matte A, Li Y, Kim YS, Linhardt RJ, Su H, Cygler M: Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution. J Mol Biol. 1999 Dec 17;294(5):1257-69.
10618199	Tkalec AL, Fink D, Blain F, Zhang-Sun G, Laliberte M, Bennett DC, Gu K, Zimmermann JJ, Su H: Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum. Appl Environ Microbiol. 2000 Jan;66(1):29-35.
11327856	Huang W, Boju L, Tkalec L, Su H, Yang HO, Gunay NS, Linhardt RJ, Kim YS, Matte A, Cygler M: Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry. 2001 Feb 27;40(8):2359-72.
12063249	Pojasek K, Raman R, Kiley P, Venkataraman G, Sasisekharan R: Biochemical characterization of the chondroitinase B active site. J Biol Chem. 2002 Aug 23;277(34):31179-86. Epub 2002 Jun 12.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2430

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
56323

# Drug_Target_1_Name:
Chondroitinase B

# Drug_Target_1_Number_of_Residues:
506

# Drug_Target_1_PDB_ID:
1DBO

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Chondroitinase B precursor
MKMLNKLAGYLLPIMVLLNVAPCLGQVVASNETLYQVVKEVKPGGLVQIADGTYKDVQLI
VSNSGKSGLPITIKALNPGKVFFTGDAKVELRGEHLILEGIWFKDGNRAIQAWKSHGPGL
VAIYGSYNRITACVFDCFDEANSAYITTSLTEDGKVPQHCRIDHCSFTDKITFDQVINLN
NTARAIKDGSVGGPGMYHRVDHCFFSNPQKPGNAGGGIRIGYYRNDIGRCLVDSNLFMRQ
DSEAEIITSKSQENVYYGNTYLNCQGTMNFRHGDHQVAINNFYIGNDQRFGYGGMFVWGS
RHVIACNYFELSETIKSRGNAALYLNPGAMASEHALAFDMLIANNAFINVNGYAIHFNPL
DERRKEYCAANRLKFETPHQLMLKGNLFFKDKPYVYPFFKDDYFIAGKNSWTGNVALGVE
KGIPVNISANRSAYKPVKIKDIQPIEGIALDLNALISKGITGKPLSWDEVRPYWLKEMPG
TYALTARLSADRAAKFKAVIKRNKEH

# Drug_Target_1_Reaction:
Eliminative cleavage of dermatan sulfate containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucurosonyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated dermatan-sulfate disaccharide (deltaUA-GalNAc-4S).

# Drug_Target_1_Signals:
1-25

# Drug_Target_1_Specific_Function:
Cleaves the glycosaminoglycan, dermatan sulfate

# Drug_Target_1_SwissProt_ID:
Q46079

# Drug_Target_1_SwissProt_Name:
CSLB_PEDHD

# Drug_Target_1_Synonyms:
Chondroitin B eliminase
Chondroitin B lyase
Chondroitin sulfate B lyase
Chondroitinase B precursor
EC 4.2.2.19

# Drug_Target_1_Theoretical_pI:
8.94

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U27583

# Drug_Target_2_GenBank_ID_Protein:
1002525

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
cslA

# Drug_Target_2_Gene_Sequence:
>2103 bp
ATGAAGAAATTATTTGTAACCTGTATAGTCTTTTTCTCTATTTTAAGTCCTGCTCTGCTT
ATTGCACAGCAGACCGGTACTGCAGAACTGATTATGAAGCGGGTGATGCTGGACCTTAAA
AAGCCTTTGCGCAATATGGATAAGGTGGCGGAAAAGAACCTGAATACGCTGCAGCCTGAC
GGTAGCTGGAAGGATGTGCCTTATAAAGATGATGCCATGACCAATTGGTTGCCAAACAAC
CACCTGCTACAATTGGAAACTATTATACAGGCTTATATTGAAAAAGATAGTCACTATTAT
GGCGACGATAAAGTGTTTGACCAGATTTCCAAAGCTTTTAAGTATTGGTATGACAGCGAC
CCGAAAAGCCGCAACTGGTGGCACAATGAAATTGCCACTCCGCAGGCCCTTGGTGAAATG
CTGATCCTGATGCGTTACGGTAAAAAGCCGCTTGATGAAGCATTGGTGCATAAATTGACC
GAAAGAATGAAGCGGGGCGAACCGGAGAAGAAAACGGGGGCCAACAAAACAGATATCGCC
CTGCATTACTTTTATCGTGCTTTGTTAACGTCTGATGAGGCTTTGCTTTCCTTCGCCGTA
AAAGAATTGTTTTATCCCGTACAGTTTGTACACTATGAGGAAGGCCTGCAATACGATTAT
TCCTACCTGCAGCACGGTCCGCAATTACAGATATCGAGCTACGGTGCCGTATTTATTACC
GGGGTACTGAAACTTGCCAATTACGTTAGGGATACCCCTTATGCTTTAAGTACCGAGAAA
CTGGCTATATTTTCAAAGTATTACCGCGACAGTTATCTGAAAGCTATCCGTGGAAGTTAT
ATGGATTTTAACGTAGAAGGCCGCGGAGTAAGCCGGCCAGACATTCTAAATAAAAAGGCA
GAAAAAAAGAGGTTGCTGGTGGCGAAGATGATCGATCTTAAGCATACTGAAGAATGGGCT
GATGCGATAGCCAGGACAGATAGCACAGTTGCGGCCGGCTATAAGATTGAGCCCTATCAC
CATCAGTTCTGGAATGGTGATTATGTGCAACATTTAAGACCTGCCTATTCTTTTAATGTT
CGTATGGTGAGTAAGCGGACCCGACGCAGTGAATCCGGCAATAAAGAAAACCTGCTGGGC
AGGTATTTATCTGATGGGGCTACTAACATACAATTGCGCGGACCAGAATACTATAACATT
ATGCCGGTATGGGAATGGGACAAGATTCCTGGCATAACCAGCCGTGATTATTTAACCGAC
AGACCTTTGACGAAGCTTTGGGGAGAGCAGGGGAGCAATGACTTTGCAGGAGGGGTGTCT
GATGGTGTATACGGGGCCAGTGCCTACGCATTGGATTACGATAGCTTACAGGCAAAGAAA
GCCTGGTTCTTTTTTGACAAAGAGATTGTATGTCTTGGTGCCGGTATCAACAGCAATGCC
CCTGAAAACATTACCACTACCCTTAACCAGAGCTGGTTAAATGGCCCGGTTATAAGTACT
GCAGGTAAAACCGGCCGGGGTAAAATAACAACGTTTAAAGCACAGGGACAGTTCTGGTTG
TTGCACGATGCGATTGGTTATTACTTTCCTGAAGGGGCCAACCTTAGTCTGAGTACCCAG
TCGCAAAAAGGCAATTGGTTCCACATCAACAATTCACATTCAAAAGATGAAGTTTCTGGT
GATGTATTTAAGCTTTGGATCAACCATGGTGCCAGGCCAGAAAATGCGCAGTATGCTTAT
ATCGTTTTGCCGGGAATAAACAAGCCGGAAGAAATTAAAAAATATAATGGAACGGCACCG
AAAGTCCTTGCCAATACCAACCAGCTGCAGGCAGTTTATCATCAGCAGTTAGATATGGTA
CAGGCTATCTTCTATACAGCTGGAAAATTAAGCGTAGCGGGCATAGAAATTGAAACAGAT
AAGCCATGTGCAGTGCTGATCAAGCACATCAATGGCAAGCAGGTAATTTGGGCTGCCGAT
CCATTGCAAAAAGAAAAGACTGCAGTGTTGAGCATCAGGGATTTAAAAACAGGAAAAACA
AATCGGGTAAAAATTGATTTTCCGCAACAGGAATTTGCAGGTGCAACGGTTGAACTGAAA
TAG

# Drug_Target_2_General_Function:
Involved in catalytic activity

# Drug_Target_2_General_References:
10329169	Fethiere J, Eggimann B, Cygler M: Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes. J Mol Biol. 1999 May 14;288(4):635-47.
10618199	Tkalec AL, Fink D, Blain F, Zhang-Sun G, Laliberte M, Bennett DC, Gu K, Zimmermann JJ, Su H: Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum. Appl Environ Microbiol. 2000 Jan;66(1):29-35.
11327856	Huang W, Boju L, Tkalec L, Su H, Yang HO, Gunay NS, Linhardt RJ, Kim YS, Matte A, Cygler M: Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry. 2001 Feb 27;40(8):2359-72.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2581

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
79695

# Drug_Target_2_Name:
Chondroitinase AC

# Drug_Target_2_Number_of_Residues:
700

# Drug_Target_2_PDB_ID:
1HMW

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02278	Lyase_8
PF02884	Lyase_8_C
PF08124	Lyase_8_N

# Drug_Target_2_Protein_Sequence:
>Chondroitinase AC precursor
MKKLFVTCIVFFSILSPALLIAQQTGTAELIMKRVMLDLKKPLRNMDKVAEKNLNTLQPD
GSWKDVPYKDDAMTNWLPNNHLLQLETIIQAYIEKDSHYYGDDKVFDQISKAFKYWYDSD
PKSRNWWHNEIATPQALGEMLILMRYGKKPLDEALVHKLTERMKRGEPEKKTGANKTDIA
LHYFYRALLTSDEALLSFAVKELFYPVQFVHYEEGLQYDYSYLQHGPQLQISSYGAVFIT
GVLKLANYVRDTPYALSTEKLAIFSKYYRDSYLKAIRGSYMDFNVEGRGVSRPDILNKKA
EKKRLLVAKMIDLKHTEEWADAIARTDSTVAAGYKIEPYHHQFWNGDYVQHLRPAYSFNV
RMVSKRTRRSESGNKENLLGRYLSDGATNIQLRGPEYYNIMPVWEWDKIPGITSRDYLTD
RPLTKLWGEQGSNDFAGGVSDGVYGASAYALDYDSLQAKKAWFFFDKEIVCLGAGINSNA
PENITTTLNQSWLNGPVISTAGKTGRGKITTFKAQGQFWLLHDAIGYYFPEGANLSLSTQ
SQKGNWFHINNSHSKDEVSGDVFKLWINHGARPENAQYAYIVLPGINKPEEIKKYNGTAP
KVLANTNQLQAVYHQQLDMVQAIFYTAGKLSVAGIEIETDKPCAVLIKHINGKQVIWAAD
PLQKEKTAVLSIRDLKTGKTNRVKIDFPQQEFAGATVELK

# Drug_Target_2_Reaction:
Eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups

# Drug_Target_2_Signals:
1-22

# Drug_Target_2_Specific_Function:
Eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4- enuronosyl groups

# Drug_Target_2_SwissProt_ID:
Q59288

# Drug_Target_2_SwissProt_Name:
CSLA_PEDHD

# Drug_Target_2_Synonyms:
Chondroitin AC eliminase
Chondroitin AC lyase
Chondroitin sulfate AC lyase
Chondroitinase AC precursor
EC 4.2.2.5

# Drug_Target_2_Theoretical_pI:
9.19

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M15824

# Drug_Target_3_GenBank_ID_Protein:
144425

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
cex

# Drug_Target_3_Gene_Sequence:
>1455 bp
ATGCCTAGGACCACGCCCGCACCCGGCCACCCGGCCCGCGGCGCCCGCACCGCTCTGCGC
ACGACGCGCCGCCGCGCGGCGACGCTCGTCGTCGGCGCCACGGTCGTGCTGCCCGCCCAG
GCCGCGACCACGCTCAAGGAGGCCGCCGACGGCGCCGGCCGGGACTTCGGCTTCGCGCTC
GACCCCAACCGGCTCTCGGAGGCGCAGTACAAGGCGATCGCCGACAGCGAGTTCAACCTC
GTCGTCGCCGAGAACGCGATGAAGTGGGACGCCACCGAGCCCTCGCAGAACAGCTTCTCC
TTCGGCGCGGGCGACCGCGTCGCGAGCTACGCCGCCGACACCGGCAAGGAGCTGTACGGC
CACACGCTCGTCTGGCACTCGCAGCTGCCCGACTGGGCGAAGAACCTCAACGGCTCCGCG
TTCGAGAGCGCGATGGTCAACCACGTGACGAAGGTCGCCGACCACTTCGAGGGCAAGGTC
GCGTCGTGGGACGTCGTCAACGAGGCGTTCGCCGACGGCGACGGCCCGCCGCAGGACTCG
GCGTTCCAGCAGAAGCTCGGCAACGGCTACATCGAGACCGCGTTCCGGGCGGCACGTGCG
GCGGACCCGACCGCCAAGCTGTGCATCAACGACTACAACGTCGAGGGCATCAACGCGAAG
AGCAACTCGCTCTACGACCTCGTCAAGGACTTCAAGGCGCGCGGCGTCCCGCTCGACTGC
GTCGGGTTCCAGTCGCACCTCATCGTCGGCCAGGTGCCGGGCGACTTCCGGCAGAACCTG
CAGCGGTTCGCGGACCTGGGCGTGGACGTGCGCATCACCGAGCTCGACATCCGCATGCGG
ACGCCCTCCGACGCGACCAAGCTCGCGACCCAGGCGGCCGACTACAAGAAGGTCGTGCAG
GCCTGCATGCAGGTGACCCGCTGCCAGGGCGTGACCGTCTGGGGCATCACCGACAAGTAC
TCGTGGGTGCCGGACGTCTTCCCGGGCGAGGGGGCCGCGCTGGTGTGGGACGCGAGCTAC
GCCAAGAAGCCGGCCTACGCCGCCGTGATGGAGGCCTTCGGCGCGAGCCCGACGCCGACG
CCCACCACGCCGACCCCGACGCCCACGACGCCGACGCCGACCCCGACGTCCGGTCCGGCC
GGGTGCCAGGTGCTGTGGGGCGTCAACCAGTGGAACACCGGCTTCACCGCGAACGTCACC
GTGAAGAACACGTCCTCCGCTCCGGTCGACGGCTGGACGCTCACGTTCAGCTTCCCGTCC
GGCCAGCAGGTCACCCAGGCGTGGAGCTCGACGGTCACGCAGTCCGGCTCGGCCGTGACG
GTCCGCAACGCCCCGTGGAACGGCTCGATCCCGGCGGGCGGCACCGCGCAGTTCGGCTTC
AACGGCTCGCACACGGGCACCAACGCCGCGCCGACGGCGTTCTCGCTCAACGGCACGCCC
TGCACGGTCGGCTGA

# Drug_Target_3_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_3_General_References:
1678739	Tull D, Withers SG, Gilkes NR, Kilburn DG, Warren RA, Aebersold R: Glutamic acid 274 is the nucleophile in the active site of a "retaining" exoglucanase from Cellulomonas fimi. J Biol Chem. 1991 Aug 25;266(24):15621-5.
1761039	Gilkes NR, Claeyssens M, Aebersold R, Henrissat B, Meinke A, Morrison HD, Kilburn DG, Warren RA, Miller RC Jr: Structural and functional relationships in two families of beta-1,4-glycanases. Eur J Biochem. 1991 Dec 5;202(2):367-77.
3096818	O'Neill G, Goh SH, Warren RA, Kilburn DG, Miller RC Jr: Structure of the gene encoding the exoglucanase of Cellulomonas fimi. Gene. 1986;44(2-3):325-30.
7766609	Xu GY, Ong E, Gilkes NR, Kilburn DG, Muhandiram DR, Harris-Brandts M, Carver JP, Kay LE, Harvey TS: Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopy. Biochemistry. 1995 May 30;34(21):6993-7009.
7910761	MacLeod AM, Lindhorst T, Withers SG, Warren RA: The acid/base catalyst in the exoglucanase/xylanase from Cellulomonas fimi is glutamic acid 127: evidence from detailed kinetic studies of mutants. Biochemistry. 1994 May 24;33(20):6371-6.
7918478	White A, Withers SG, Gilkes NR, Rose DR: Crystal structure of the catalytic domain of the beta-1,4-glycanase cex from Cellulomonas fimi. Biochemistry. 1994 Oct 25;33(42):12546-52.
8564541	White A, Tull D, Johns K, Withers SG, Rose DR: Crystallographic observation of a covalent catalytic intermediate in a beta-glycosidase. Nat Struct Biol. 1996 Feb;3(2):149-54.
9537990	Notenboom V, Birsan C, Warren RA, Withers SG, Rose DR: Exploring the cellulose/xylan specificity of the beta-1,4-glycanase cex from Cellulomonas fimi through crystallography and mutation. Biochemistry. 1998 Apr 7;37(14):4751-8.
9731776	Notenboom V, Birsan C, Nitz M, Rose DR, Warren RA, Withers SG: Insights into transition state stabilization of the beta-1,4-glycosidase Cex by covalent intermediate accumulation in active site mutants. Nat Struct Biol. 1998 Sep;5(9):812-8.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2448

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
51291

# Drug_Target_3_Name:
Exoglucanase/xylanase [Includes: Exoglucanase

# Drug_Target_3_Number_of_Residues:
484

# Drug_Target_3_PDB_ID:
1J01

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF00553	CBM_2

# Drug_Target_3_Protein_Sequence:
>Exoglucanase/xylanase precursor [Includes: Exoglucanase
MPRTTPAPGHPARGARTALRTTRRRAATLVVGATVVLPAQAATTLKEAADGAGRDFGFAL
DPNRLSEAQYKAIADSEFNLVVAENAMKWDATEPSQNSFSFGAGDRVASYAADTGKELYG
HTLVWHSQLPDWAKNLNGSAFESAMVNHVTKVADHFEGKVASWDVVNEAFADGDGPPQDS
AFQQKLGNGYIETAFRAARAADPTAKLCINDYNVEGINAKSNSLYDLVKDFKARGVPLDC
VGFQSHLIVGQVPGDFRQNLQRFADLGVDVRITELDIRMRTPSDATKLATQAADYKKVVQ
ACMQVTRCQGVTVWGITDKYSWVPDVFPGEGAALVWDASYAKKPAYAAVMEAFGASPTPT
PTTPTPTPTTPTPTPTSGPAGCQVLWGVNQWNTGFTANVTVKNTSSAPVDGWTLTFSFPS
GQQVTQAWSSTVTQSGSAVTVRNAPWNGSIPAGGTAQFGFNGSHTGTNAAPTAFSLNGTP
CTVG

# Drug_Target_3_Reaction:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans REFERENCE 1 [PMID:14403433] AUTHORS HOWARD BH, JONES G, PURDOM MR. TITLE The pentosanases of some rumen bacteria. JOURNAL Biochem. J. 74 (1960) 173-80. ORGANISM Triticum aestivum [GN:etae]

# Drug_Target_3_Signals:
1-41

# Drug_Target_3_Specific_Function:
The biological conversion of cellulose to glucose generally requires three types of hydrolytic enzymes:(1) Endoglucanases which cut internal beta-1,4-glucosidic bonds; (2) Exocellobiohydrolases that cut the dissaccharide cellobiose from the nonreducing end of the cellulose polymer chain; (3) Beta-1,4- glucosidases which hydrolyze the cellobiose and other short cello- oligosaccharides to glucose

# Drug_Target_3_SwissProt_ID:
P07986

# Drug_Target_3_SwissProt_Name:
GUX_CELFI

# Drug_Target_3_Synonyms:
1,4-beta-cellobiohydrolase
Beta-1,4- glycanase CEX
EC 3.2.1.8
EC 3.2.1.91
Endo-1,4-beta-xylanase B
Exocellobiohydrolase
Exoglucanase/xylanase

# Drug_Target_3_Theoretical_pI:
6.62

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
U60828

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
galM

# Drug_Target_4_Gene_Sequence:
>1020 bp
ATGGAAATTAAAATAAGAGATTTTGGCTTAGGAAGTGACTTAATTAGTCTAACCAATAAA
GCAGGTGTCACAATTTCTTTTACAAATCTGGGCGCTCGGATTGTTGACTGGCAAAAAGAT
GGAAAGCATCTGATTCTAGGCTTTGATTCAGCTAAAGAATATTTAGAAAAAGATGCCTAT
CCTGGTGCAACAGTTGGACCTACAGCAGGAAGAATTAAGGATGGTTTGGTCAAAATTTCT
GGAAAAGATTATATCTTAAATCAAAATGAAGGCCCTCAAACCTTACATGGTGGGGAAGAA
AGTATTCATACTAAACTTTGGACATATGAAGTTACCGATTTAGGAGCTGAAGTTCAAGTC
AAATTTTCCTTAGTTACTAATGACGGAACAAATGGTTATCCTGGTAAAATAGAAATGTCA
GTAACTCATTCTTTTGATGATTACAATAAGTGGAAAATTCATTATGAGGCCATTTCTGAT
AAAGACACTGTGTTTAATCCAACTGGGCATGTCTATTTTAATTTGAATGGTGATGCTAGT
GAATCTGTTGAAAATCATGGACTTCGACTGGCCGCTTCAAGATTTGTTCCTTTAAAAGAC
CAAACAGAAATTGTTCGTGGTGATATCGTTGATATAAAAAATACAGACTTGGATTTCCGT
CAGGAAAAACAATTATCAAATGCCTTCAATTCTAATATGGAACAAGTTCAATTAGTTAAA
GGAATTGACCATCCTTTCTTGTTAGACCAGTTAGGACTTGATAAAGAACAAGCTCGTTTA
ACGCTTGATGATACTTCAATTTCAGTCTTTACCGACCAACCAAGTATTGTGATATTTACA
GCAAATTTTGGTGATTTAGGAACTCTTTATCATGAGAAAAAGCAAGTGCACCATGGTGGA
ATTACTTTTGAATGTCAAGTATCACCTGGGTCTGAGCAAATTCCAGAGCTTGGAGATATC
AGCCTAAAAGCGGGAGAAAAATATCAAGCAACCACAATTTACAGCTTGCATACAAAATAA

# Drug_Target_4_General_Function:
Involved in isomerase activity

# Drug_Target_4_General_References:
Not Available

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4830

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
37611

# Drug_Target_4_Name:
Aldose 1-epimerase

# Drug_Target_4_Number_of_Residues:
339

# Drug_Target_4_PDB_ID:
1MN0

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01263	Aldose_epim

# Drug_Target_4_Protein_Sequence:
>Aldose 1-epimerase
MEIKIRDFGLGSDLISLTNKAGVTISFTNLGARIVDWQKDGKHLILGFDSAKEYLEKDAY
PGATVGPTAGRIKDGLVKISGKDYILNQNEGPQTLHGGEESIHTKLWTYEVTDLGAEVQV
KFSLVTNDGTNGYPGKIEMSVTHSFDDYNKWKIHYEAISDKDTVFNPTGHVYFNLNGDAS
ESVENHGLRLAASRFVPLKDQTEIVRGDIVDIKNTDLDFRQEKQLSNAFNSNMEQVQLVK
GIDHPFLLDQLGLDKEQARLTLDDTSISVFTDQPSIVIFTANFGDLGTLYHEKKQVHHGG
ITFECQVSPGSEQIPELGDISLKAGEKYQATTIYSLHTK

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
Q9ZB17

# Drug_Target_4_SwissProt_Name:
Q9ZB17_9LACT

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
5.01

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasmic

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Z48928

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
Not Available

# Drug_Target_5_Gene_Sequence:
>1821 bp
ATGAAAAAGATCCAGCAACTCCTCATGCTCTCCCTGATTAGCTCAACACTAATTGCCTGT
GGCGGCGGTGGAGGGGGCGGTTCAACACCAACCACCAGCAGCTCACCCCAATCCTCTAGT
CCAGCATCGACGCCATCCAGTGCTTCATCCTCATCGATCATATCCTCCTCATCGCTATCA
TCATCGCTGTCTTCCTCATCACTATCCTCGTCATCGCTGTCTTCTTCATCGGCGAGCAGT
GTTAGCAGCTCCAGTGTCGCTGCCAGCGAGGGCAATGTTGTTATAGAGGTGGACATGGCA
AATGGCTGGAGAGGCAACGCATCAGGCAGTACCAGCCATTCCGGTATTACCTACAGTGCC
GATGGCGTTACCTTTGCCGCACTGGGTGATGGCGTGGGCGCTGTTTTTGATATTGCCCGA
CCAACCACACTGGAAGATGCTGTGATAGCAATGGTTGTTAATGTCAGCGCTGAATTTAAG
GCCAGTGAAGCCAACTTGCAGATATTTGCCCAGTTAAAAGAAGACTGGTCAAAGGGCGAA
TGGGATTGTCTGGCGGCCAGCAGCGAACTCACTGCGGATACTGACCTAACCCTGACCTGC
ACCATTGATGAAGACGACGATAAATTCAACCAAACGGCGCGCGATGTACAAGTCGGTATC
CAGGCCAAGGGAACACCCGCCGGAACTATCACCATTAAAAGCGTCACCATTACACTCGCA
CAGGAAGCCTATTCAGCCAATGTCGATCACCTGCGCGACCTGGCCCCCAGCGATTTCCCC
ATTGGCGTCGCCGTGTCCAATACCGACTCCGCCACTTACAACCTGCTCACCAACAGCAGA
GAGCAGGCTGTGGTTAAAAAGCACTTCAATCATTTAACTGCCGGTAACATCATGAAGATG
AGTTACATGCAACCTACCGAGGGCAATTTTAACTTCACCAACGCCGACGCCTTTGTGGAT
TGGGCCACTGAAAATAATATGACGGTGCACGGCCACGCCCTGGTATGGCATTCCGATTAC
CAGGTTCCCAACTTTATGAAAAACTGGGCAGGCAGTGCAGAAGACTTTTTAGCGGCCTTG
GACACACATATCACCACCATTGTCGATCACTACGAAGCCAAGGGTAACCTCGTCAGTTGG
GACGTCGTTAACGAAGCCATCGACGACAACAGTCCGGCAAACTTCCGCACGACGGATTCT
GCGTTTTATGTGAAGAGCGGAAACAGCTCTGTCTATATTGAGCGCGCCTTCCAGACCGCG
CGCGCGGCAGATCCCGCTGTGATCCTCTACTACAACGACTACAACATTGAGCAGAACAAT
GCCAAGACCACCAAAATGGTCGATATGGTCAAGGACTTCCAGGCGCGCAGTATCCCGATT
GACGGTGTGGGCTTCCAGATGCATGTCTGTATGAACTATCCATCCATCGCCAACATTTCT
GCCGCGATGAAGAAAGTGGTCGACCTTGGCTTGCTGGTAAAAATTACCGAACTGGATGTT
GCCGTCAACCAGCCCCATTGCGATGCGTATCCGGCCAACAAAATCAATCCGCTGACCGAA
GCGGCGCAATTGGCCCAGAAAAAACGCTACTGCGACGTAGTGAAGGCCTATCTGGATACA
GTCCCGGTGAATCAGCGCGGCGGTATCAGCGTCTGGGGAACTACCGATGCCAACACCTGG
CTTGATGGCCTGTACAGAGAACAGTTTGAGGATGAAAAAATTTCCTGGCCCTTGCTGTTC
GACAACAACTACAACGACAAACCTGCACTGCGCGGTTTTGCCGATGCGTTAATCGGTACG
CAATGTACTAATACACATTGA

# Drug_Target_5_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_5_General_References:
11598143	Szabo L, Jamal S, Xie H, Charnock SJ, Bolam DN, Gilbert HJ, Davies GJ: Structure of a family 15 carbohydrate-binding module in complex with xylopentaose. Evidence that xylan binds in an approximate 3-fold helical conformation. J Biol Chem. 2001 Dec 28;276(52):49061-5. Epub 2001 Oct 11.
7492333	Millward-Sadler SJ, Davidson K, Hazlewood GP, Black GW, Gilbert HJ, Clarke JH: Novel cellulose-binding domains, NodB homologues and conserved modular architecture in xylanases from the aerobic soil bacteria Pseudomonas fluorescens subsp. cellulosa and Cellvibrio mixtus. Biochem J. 1995 Nov 15;312 ( Pt 1):39-48.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
5245

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
64884

# Drug_Target_5_Name:
Endo-beta-1,4-xylanase

# Drug_Target_5_Number_of_Residues:
606

# Drug_Target_5_PDB_ID:
1US3

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF03426	CBM_15

# Drug_Target_5_Protein_Sequence:
>Endo-beta-1,4-xylanase
MKKIQQLLMLSLISSTLIACGGGGGGGSTPTTSSSPQSSSPASTPSSASSSSIISSSSLS
SSLSSSSLSSSSLSSSSASSVSSSSVAASEGNVVIEVDMANGWRGNASGSTSHSGITYSA
DGVTFAALGDGVGAVFDIARPTTLEDAVIAMVVNVSAEFKASEANLQIFAQLKEDWSKGE
WDCLAASSELTADTDLTLTCTIDEDDDKFNQTARDVQVGIQAKGTPAGTITIKSVTITLA
QEAYSANVDHLRDLAPSDFPIGVAVSNTDSATYNLLTNSREQAVVKKHFNHLTAGNIMKM
SYMQPTEGNFNFTNADAFVDWATENNMTVHGHALVWHSDYQVPNFMKNWAGSAEDFLAAL
DTHITTIVDHYEAKGNLVSWDVVNEAIDDNSPANFRTTDSAFYVKSGNSSVYIERAFQTA
RAADPAVILYYNDYNIEQNNAKTTKMVDMVKDFQARSIPIDGVGFQMHVCMNYPSIANIS
AAMKKVVDLGLLVKITELDVAVNQPHCDAYPANKINPLTEAAQLAQKKRYCDVVKAYLDT
VPVNQRGGISVWGTTDANTWLDGLYREQFEDEKISWPLLFDNNYNDKPALRGFADALIGT
QCTNTH

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
1-19

# Drug_Target_5_Specific_Function:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans

# Drug_Target_5_SwissProt_ID:
Q59675

# Drug_Target_5_SwissProt_Name:
Q59675_9GAMM

# Drug_Target_5_Synonyms:
EC 3.2.1.8
Endo-beta-1,4-xylanase precursor

# Drug_Target_5_Theoretical_pI:
4.48

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
BA000004

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
BH2105

# Drug_Target_6_Gene_Sequence:
>1167 bp
CTAGTGTTCCTCTTCTTGGCCCTCAGGAAACCAAATTTTAAAATTGCCGCTTAGTGCGAG
CATCGCAAACAAATATAAACAATTATCGTAATAACGGCGGTTGCCGGTGCGAACCGGTGT
GTTCCAGAACAAATCCACATTAGCTTTAGCGTATGGTCCATCAACAGAGGCTAAAGAACC
CATCGCGTTAGTAGCAATCAGTCCGACAGGGTGCAATGATTTCTCTTCGAACGGTTCCCC
GTCTATTTTATAGCGGCGGTAGTCTTCAGGCTCCTTATCTGCAAAAAACGCCTGGATCTT
ATTTATCTCTTCTGCCGACCACTCGCTTCCTCCGAACCATTCAGCGTCAAGTCCAATATT
AGCAGCCACACGATAAGAATCGCTAAAAAAGTGGCCGTATCCCTTTTCATCATTTGGCGT
TCCATCATAGTAAGCATACTCAGGCGCAAGTCCTGTTTCAGGATGGCAAGCTATTTTCAA
ATACTCCCGGCTCGCTTCAGCAGCCTCTTTCCAGAAGACGCGGTCCTCTTCGTTTGCCCA
TAAACTGAACAGTTCATAAAAATGGGGGAGATGATAAGAGGGATCACTGAACTCCACTTC
AGGTATGAATTTAATGAGCTTATTATCCCGGTTCCACATTGGATGGCCAGGACCACCTTC
ACCATTGTGCACGCAAGTATGAAGTAGCTTACGAGCTTGTTCGCTGTAATTAAACGGCTG
TTCATCACCATCGCCCCAGCGGTGCGAAGCAAAAAATAATGCAAGGGCAAAATATTCCTC
TCCGTCCGGAGCTGGGCCCCAGGAGTTTTTAGTGCCATCAGGCTGGCATGACCAAGCGAA
GTAGCCCGCGTGCACGCCTTCCGTCATATACATATTCTTCATCGTCCAATTCCAGATCCG
GTCGAAAATATCCTTTCTGTCCATTTGAACAGCCATCATCATTCCGTAGGACATTCCTTC
AGTCCGCACATCGAGGTTTCCCGTATCGAGGAGATAACCTAGATCATCGCCCACTTCATA
ATAAATTTTCGTTTCTGGGTTATCGCCAAAAAGCTGTTCCCATGTGTCCTTAACTCGTTC
TTGGATTTCCGCTTCCGAATACCCGAATTCCTTGAAAAGATTTCGGTACTCCCTCGTATA
AAATGCACCTTCTGTCGTTTTCTTCAT

# Drug_Target_6_General_Function:
Involved in catalytic activity

# Drug_Target_6_General_References:
11058132	Takami H, Nakasone K, Takaki Y, Maeno G, Sasaki R, Masui N, Fuji F, Hirama C, Nakamura Y, Ogasawara N, Kuhara S, Horikoshi K: Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. Nucleic Acids Res. 2000 Nov 1;28(21):4317-31.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
5246

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
45010

# Drug_Target_6_Name:
Xylanase Y

# Drug_Target_6_Number_of_Residues:
388

# Drug_Target_6_PDB_ID:
1WU5

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01270	Glyco_hydro_8

# Drug_Target_6_Protein_Sequence:
>Xylanase Y
MKKTTEGAFYTREYRNLFKEFGYSEAEIQERVKDTWEQLFGDNPETKIYYEVGDDLGYLL
DTGNLDVRTEGMSYGMMMAVQMDRKDIFDRIWNWTMKNMYMTEGVHAGYFAWSCQPDGTK
NSWGPAPDGEEYFALALFFASHRWGDGDEQPFNYSEQARKLLHTCVHNGEGGPGHPMWNR
DNKLIKFIPEVEFSDPSYHLPHFYELFSLWANEEDRVFWKEAAEASREYLKIACHPETGL
APEYAYYDGTPNDEKGYGHFFSDSYRVAANIGLDAEWFGGSEWSAEEINKIQAFFADKEP
EDYRRYKIDGEPFEEKSLHPVGLIATNAMGSLASVDGPYAKANVDLFWNTPVRTGNRRYY
DNCLYLFAMLALSGNFKIWFPEGQEEEH

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q9KB30

# Drug_Target_6_SwissProt_Name:
REOX_BACHD

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
4.45

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Secreted protein

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
Z29080

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
Not Available

# Drug_Target_7_Gene_Sequence:
>1224 bp
ATGCGGAACGTCGTGCGTAAACCATTGACAATCGGACTCGCTTTAACACTATTATTGCCC
ATGGGAATGACGGCAACATCAGCGAAGAATGCAGATTCCTATGCGAAAAAACCTCACATC
AGCGCATTGAATGCCCCACAATTGGATCAACGCTACAAAAACGAGTTCACGATTGGTGCG
GCAGTAGAACCTTATCAACTACAAAATGAAAAAGACGTACAAATGCTAAAGCGCCACTTC
AACAGCATTGTTGCCGAGAACGTAATGAAACCGATCAGCATTCAACCTGAGGAAGGAAAA
TTCAATTTTGAACAAGCGGATCGAATTGTGAAGTTCGCTAAGGCAAATGGCATGGATATT
CGCTTCCATACACTCGTTTGGCACAGCCAAGTACCTCAATGGTTCTTTCTTGACAAGGAA
GGTAAGCCAATGGTTAATGAAACAGATCCAGTGAAACGTGAACAAAATAAACAACTGCTG
TTAAAACGACTTGAAACTCATATTAAAACGATCGTCGAGCGGTACAAAGATGACATTAAG
TACTGGGACGTTGTAAATGAGGTTGTGGGGGACGACGGAAAACTGCGCAACTCTCCATGG
TATCAAATCGCCGGCATCGATTATATTAAAGTGGCATTCCAAGCAGCTAGAAAATATGGC
GGAGACAACATTAAGCTTTACATGAATGATTACAATACAGAAGTCGAACCGAAGCGAACC
GCTCTTTACAATTTAGTCAAACAACTGAAAGAAGAGGGTGTTCCGATCGACGGCATCGGC
CATCAATCCCACATCCAAATCGGCTGGCCTTCTGAAGCAGAAATCGAGAAAACGATTAAC
ATGTTCGCCGCTCTCGGTTTAGACAACCAAATCACTGAGCTTGATGTGAGCATGTACGGT
TGGCCGCCGCGCGCTTACCCGACGTATGACGCCATTCCAAAACAAAAGTTTTTGGATCAG
GCAGCGCGCTATGATCGTTTGTTCAAACTGTATGAAAAGTTGAGCGATAAAATTAGCAAC
GTCACCTTCTGGGGCATCGCCGACAATCATACGTGGCTCGACAGCCGTGCGGATGTGTAC
TATGACGCCAACGGGAATGTTGTGGTTGACCCGAACGCTCCGTACGCAAAAGTGGAAAAA
GGGAAAGGAAAAGATGCGCCGTTCGTTTTTGGACCGGATTACAAAGTCAAACCCGCATAT
TGGGCTATTATCGACCACAAATAG

# Drug_Target_7_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_7_General_References:
8031084	Gat O, Lapidot A, Alchanati I, Regueros C, Shoham Y: Cloning and DNA sequence of the gene coding for Bacillus stearothermophilus T-6 xylanase. Appl Environ Microbiol. 1994 Jun;60(6):1889-96.
8328796	Khasin A, Alchanati I, Shoham Y: Purification and characterization of a thermostable xylanase from Bacillus stearothermophilus T-6. Appl Environ Microbiol. 1993 Jun;59(6):1725-30.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
5247

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
46764

# Drug_Target_7_Name:
Endo-1,4-beta-xylanase

# Drug_Target_7_Number_of_Residues:
407

# Drug_Target_7_PDB_ID:
1R87

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00331	Glyco_hydro_10

# Drug_Target_7_Protein_Sequence:
>Endo-1,4-beta-xylanase
MRNVVRKPLTIGLALTLLLPMGMTATSAKNADSYAKKPHISALNAPQLDQRYKNEFTIGA
AVEPYQLQNEKDVQMLKRHFNSIVAENVMKPISIQPEEGKFNFEQADRIVKFAKANGMDI
RFHTLVWHSQVPQWFFLDKEGKPMVNETDPVKREQNKQLLLKRLETHIKTIVERYKDDIK
YWDVVNEVVGDDGKLRNSPWYQIAGIDYIKVAFQAARKYGGDNIKLYMNDYNTEVEPKRT
ALYNLVKQLKEEGVPIDGIGHQSHIQIGWPSEAEIEKTINMFAALGLDNQITELDVSMYG
WPPRAYPTYDAIPKQKFLDQAARYDRLFKLYEKLSDKISNVTFWGIADNHTWLDSRADVY
YDANGNVVVDPNAPYAKVEKGKGKDAPFVFGPDYKVKPAYWAIIDHK

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
1-28

# Drug_Target_7_Specific_Function:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans

# Drug_Target_7_SwissProt_ID:
P40943

# Drug_Target_7_SwissProt_Name:
XYN1_GEOSE

# Drug_Target_7_Synonyms:
1,4-beta-D- xylan xylanohydrolase
EC 3.2.1.8
Endo-1,4-beta-xylanase precursor
Xylanase

# Drug_Target_7_Theoretical_pI:
8.81

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
Not Available

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
Not Available

# Drug_Target_8_Gene_Sequence:
Not Available

# Drug_Target_8_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_8_General_References:
Not Available

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
5023

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
23308

# Drug_Target_8_Name:
Glycoside hydrolase

# Drug_Target_8_Number_of_Residues:
209

# Drug_Target_8_PDB_ID:
1H4H

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00457	Glyco_hydro_11

# Drug_Target_8_Protein_Sequence:
>Glycoside hydrolase
QIVTDNSIGNHDGYDYEFWKDSGGSGTMILNHGGTFSAQWNNVNNILFRKGKKFNETQTH
QQVGNMSINYGANFQPNGNAYLCVYGWTVDPLVAYYIVDSWGNWRPPGATPKGTITVDGG
TYDIYETLRVNQPSIKGIATFKQYWSVRRSKRTSGTISVSNHFRAWENLGMNMGKMYEVA
LTVEGYQSSGSANVYSNTLRINGNPLSTI

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
Q7SIE2

# Drug_Target_8_SwissProt_Name:
Q7SIE2_BACAG

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
9.12

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Secreted protein

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AJ508403

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
xynA

# Drug_Target_9_Gene_Sequence:
>1965 bp
ATGAAGCGTAAGGTTAAGAAGATGGCAGCTATGGCAACGAGTATAATTATGGCTATCATG
ATCATCCTACATAGTATACCAGTACTCGCCGGGCGAATAATTTACGACAATGAGACAGGC
ACACATGGAGGCTACGACTATGAGCTCTGGAAAGACTACGGAAATACGATTATGGAACTT
AACGACGGTGGTACTTTTAGTTGTCAATGGAGTAATATCGGTAATGCACTATTTAGAAAA
GGGAGAAAATTTAATTCCGACAAAACCTATCAAGAATTAGGAGATATAGTAGTTGAATAT
GGCTGTGATTACAATCCAAACGGAAATTCCTATTTGTGTGTTTACGGTTGGACAAGAAAT
CCACTGGTTGAATATTACATTGTAGAAAGCTGGGGCAGCTGGCGTCCACCTGGAGCAACA
CCCAAAGGAACCATCACAGTGGATGGCGGTACTTATGAAATATATGAAACTACCCGGGTA
AATCAGCCTTCCATCGATGGAACTGCGACATTCCAACAATATTGGAGTGTTCGTACATCC
AAGAGAACAAGCGGAACAATATCTGTCACTGAACATTTTAAACAGTGGGAAAGAATGGGC
ATGCGAATGGGTAAGATGTATGAAGTTGCTCTTACCGTTGAAGGTTATCAGAGCAGTGGG
TACGCTAATGTATACAAGAATGAAATCAGAATAGGTGCAAATCCAACTCCTGCCCCATCT
CAAAGCCCAATTAGAAGAGATGCATTTTCAATAATCGAAGCGGAAGAATATAACAGCACA
AATTCCTCCACTTTACAAGTGATTGGAACGCCAAATAATGGCAGAGGAATTGGTTATATT
GAAAATGGTAATACCGTAACTTACAGCAATATAGATTTTGGTAGTGGTGCAACAGGGTTC
TCTGCAACTGTTGCAACGGAGGTTAATACCTCAATTCAAATCCGTTCTGACAGTCCTACC
GGAACTCTACTTGGTACCTTATATGTAAGTTCTACCGGCAGCTGGAATACATATCAAACC
GTATCTACAAACATCAGCAAAATTACCGGCGTTCATGATATTGTATTGGTATTCTCAGGT
CCAGTCAATGTGGACAACTTCATATTTAGCAGAAGTTCACCAGTGCCTGCACCTGGTGAT
AACACAAGAGACGCATATTCTATCATTCAGGCCGAGGATTATGACAGCAGTTATGGCCCC
AACCTTCAAATCTTTAGCTTACCAGGCGGTGGCAGCGCCATTGGCTATATTGAAAATGGT
TATTCCACTACCTATAATAACGTTAATTTCGCCAACGGCTTAAGTTCTATAACAGCAAGA
GTTGCCACTCAGATCTCAACTTCCATTCAGGTGAGAGCAGGAGGAGCAACCGGTACTTTA
CTTGGTACAATATATGTTCCTTCGACAAATAGTTGGGATTCTTATCAGAATGTAACTGCC
AACCTTAGCAATATTACAGGTGTGCATGATATTACCCTTGTCTTTTCAGGACCAGTGAAT
GTGGACTACTTCGTATTTACACCAGCAAATGTAAATTCAGGGCCTACCTCCCCTGTCGGA
GGTACAAGAAGTGCATTTTCCAATATTCAAGCCGAAGATTATGACAGCAGTTATGGTCCC
AACCTTCAAATCTTTAGCTTACCAGGTGGTGGCAGCGCCATTGGCTATATTGAAAATGGT
TATTCCACTACCTATAAAAATATTGATTTTGGTGACGGCGCAACGTCCGTAACAGCAAGA
GTAGCTACCCAGAATGCTACTACCATTCAGGTAAGATTGGGAAGTCCATCGGGTACATTA
CTTGGAACAATTTACGTGGGGTCCACAGGAAGCTTTGATACTTATAGGGATGTATCCGCT
ACCATTAGTAATACTGCGGGTGTAAAAGATATTGTTCTTGTATTCTCAGGTCCTGTTAAT
GTTGACTGGTTTGTATTCTCAAAATTCAGGAACTTAAGGGTATAG

# Drug_Target_9_General_Function:
Involved in carbohydrate binding

# Drug_Target_9_General_References:
11849546	Boraston AB, McLean BW, Chen G, Li A, Warren RA, Kilburn DG: Co-operative binding of triplicate carbohydrate-binding modules from a thermophilic xylanase. Mol Microbiol. 2002 Jan;43(1):187-94.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
4669

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
70151

# Drug_Target_9_Name:
Endo-1,4-beta-xylanase A

# Drug_Target_9_Number_of_Residues:
651

# Drug_Target_9_PDB_ID:
Not Available

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00457	Glyco_hydro_11
PF03422	CBM_6

# Drug_Target_9_Protein_Sequence:
>Endo-1,4-beta-xylanase A
MKRKVKKMAAMATSIIMAIMIILHSIPVLAGRIIYDNETGTHGGYDYELWKDYGNTIMEL
NDGGTFSCQWSNIGNALFRKGRKFNSDKTYQELGDIVVEYGCDYNPNGNSYLCVYGWTRN
PLVEYYIVESWGSWRPPGATPKGTITVDGGTYEIYETTRVNQPSIDGTATFQQYWSVRTS
KRTSGTISVTEHFKQWERMGMRMGKMYEVALTVEGYQSSGYANVYKNEIRIGANPTPAPS
QSPIRRDAFSIIEAEEYNSTNSSTLQVIGTPNNGRGIGYIENGNTVTYSNIDFGSGATGF
SATVATEVNTSIQIRSDSPTGTLLGTLYVSSTGSWNTYQTVSTNISKITGVHDIVLVFSG
PVNVDNFIFSRSSPVPAPGDNTRDAYSIIQAEDYDSSYGPNLQIFSLPGGGSAIGYIENG
YSTTYNNVNFANGLSSITARVATQISTSIQVRAGGATGTLLGTIYVPSTNSWDSYQNVTA
NLSNITGVHDITLVFSGPVNVDYFVFTPANVNSGPTSPVGGTRSAFSNIQAEDYDSSYGP
NLQIFSLPGGGSAIGYIENGYSTTYKNIDFGDGATSVTARVATQNATTIQVRLGSPSGTL
LGTIYVGSTGSFDTYRDVSATISNTAGVKDIVLVFSGPVNVDWFVFSKSGT

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
1-30

# Drug_Target_9_Specific_Function:
Endoxylanase that degrades arabinoxylan and glucuronoxylan to xylobiose and xylotriose (in vitro)

# Drug_Target_9_SwissProt_ID:
Q8GJ44

# Drug_Target_9_SwissProt_Name:
XYNA1_CLOSR

# Drug_Target_9_Synonyms:
1,4-beta-D-xylan xylanohydrolase A
EC 3.2.1.8
Endo-1,4-beta-xylanase A precursor
Xylanase 11A
Xyn11A

# Drug_Target_9_Theoretical_pI:
4.88

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03389
